Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Matea Pavešković und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuronal Plasticity, Synapses, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIA NIH HHS, Wellcome Trust.
Themen: Demenz
Abstract (Originalsprache)
CD2-Associated protein (CD2AP) is a candidate susceptibility gene for Alzheimer’s disease, but its role in the mammalian central nervous system remains largely unknown. We show that CD2AP protein is broadly expressed in the adult mouse brain, including within cortical and hippocampal neurons, where it is detected at pre-synaptic terminals. Deletion of Cd2ap altered dendritic branching and spine density, and impaired ubiquitin-proteasome system activity. Moreover, in mice harboring either one or two copies of a germline Cd2ap null allele, we noted increased paired-pulse facilitation at hippocampal Schaffer-collateral synapses, consistent with a haploinsufficient requirement for pre-synaptic release. Whereas conditional Cd2ap knockout in the brain revealed no gross behavioral deficits in either 3.5- or 12-month-old mice, Cd2ap heterozygous mice demonstrated subtle impairments in discrimination learning using a touchscreen task. Based on unbiased proteomics, partial or complete loss of Cd2ap triggered perturbation of proteins with roles in protein folding, lipid metabolism, proteostasis, and synaptic function. Overall, our results reveal conserved, dose-sensitive requirements for CD2AP in the maintenance of neuronal structure and function, including synaptic homeostasis and plasticity, and inform our understanding of possible cell-type specific mechanisms in Alzheimer’s Disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States.
- Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund Street, Houston, TX 77030, United States.
- Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States.
- Quantitative and Computational Biology Program, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States.
- Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States.
- Development, Disease Models, and Therapeutics Graduate Program, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States.
ORCID-Profile: Evelyne K Tantry, Joshua M Shulman
Förderung
- NIH HHS
- NIA NIH HHS
- Wellcome Trust
- Alzheimer's Association fellowship
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NICHD NIH HHS
- Burroughs Wellcome Fund
- NIH
Zitieren
APA
Pavešković, M., De-Paula, R. B., Ojelade, S. A., Tantry, E. K., Kochukov, M. Y., Bao, S., Veeraragavan, S., Garza, A. R., Srivastava, S., Song, S. Y., Fujita, M., Duong, D. M., Bennett, D. A., De Jager, P. L., Seyfried, N. T., Dickinson, M. E., Heaney, J. D., Arenkiel, B. R., & Shulman, J. M. (2024). Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae115
Vancouver
Pavešković M, De-Paula RB, Ojelade SA, Tantry EK, Kochukov MY, Bao S, et al. Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae115
BibTeX
@article{Pavekovi2024,
author = {Pavešković, Matea and De-Paula, Ruth B and Ojelade, Shamsideen A and Tantry, Evelyne K and Kochukov, Mikhail Y and Bao, Suyang and Veeraragavan, Surabi and Garza, Alexandra R and Srivastava, Snigdha and Song, Si-Yuan and Fujita, Masashi and Duong, Duc M and Bennett, David A and De Jager, Philip L and Seyfried, Nicholas T and Dickinson, Mary E and Heaney, Jason D and Arenkiel, Benjamin R and Shulman, Joshua M},
title = {Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae115}
}
EUVIMED